Dominiek Mazure
Overview
Explore the profile of Dominiek Mazure including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heyrman B, Meers S, De Becker A, Wouters K, Van Hoof A, Velde A, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444406
Patients with myelodysplastic syndromes suffer from an impaired quality of life that is only partially explained by physical symptoms. In an observational study, we aimed to investigate the impact of...
2.
Delanghe S, Nguyen T, Mazure D, Dendooven A, Speeckaert M
Diagnostics (Basel)
. 2023 Jan;
13(1).
PMID: 36611303
Myelodysplastic syndromes (MDS) are a group of clonal myeloid disorders distinguished by dysplastic bone marrow and peripheral blood cells, ineffective hematopoiesis, and an increased risk of developing acute myeloid leukemia...
3.
Decruyenaere P, Mazure D, Moors I, Van Dorpe J, Van der Linden M, Denys B, et al.
Acta Clin Belg
. 2022 Jan;
78(1):58-66.
PMID: 35098906
Background: Systemic mastocytosis (SM) is a rare myeloproliferative disease that results from a clonal proliferation of abnormal mast cells in one or more extra-cutaneous organs. Systemic mastocytosis with an associated...
4.
Rijneveld A, van der Holt B, de Weerdt O, Biemond B, van de Loosdrecht A, van der Wagen L, et al.
Blood Adv
. 2021 Dec;
6(4):1115-1125.
PMID: 34883506
Clofarabine (CLO) is a nucleoside analog with efficacy in relapsed/refractory acute lymphoblastic leukemia (ALL). This randomized phase 3 study aimed to evaluate whether CLO added to induction and whether consolidation...
5.
Devos T, Havelange V, Theunissen K, Meers S, Benghiat F, Gadisseur A, et al.
Ann Hematol
. 2021 May;
100(7):1723-1732.
PMID: 33942128
Data on clinical use of ponatinib are limited. This prospective registry aimed to evaluate outcomes of ponatinib treatment in routine practice over 3 years (2016-2019) in Belgium (NCT03678454). Patients with...
6.
Delie A, Verlinden A, Beel K, Deeren D, Mazure D, Baron F, et al.
Acta Clin Belg
. 2020 May;
76(6):500-508.
PMID: 32362204
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment option in both adult and pediatric patients with malignant and non-malignant hematological diseases. Chimerism analysis, which determines the donor or...
7.
Fenaux P, Platzbecker U, Mufti G, Garcia-Manero G, Buckstein R, Santini V, et al.
N Engl J Med
. 2020 Jan;
382(2):140-151.
PMID: 31914241
Background: Patients with anemia and lower-risk myelodysplastic syndromes in whom erythropoiesis-stimulating agent therapy is not effective generally become dependent on red-cell transfusions. Luspatercept, a recombinant fusion protein that binds transforming...
8.
Bogaert D, Laureys G, Naesens L, Mazure D, De Bruyne M, Hsu A, et al.
Br J Haematol
. 2019 Nov;
188(5):768-773.
PMID: 31710708
GATA2 deficiency, first described in 2011, is a bone marrow failure disorder resulting in a complex haematological and immunodeficiency syndrome characterised by cytopenias, severe infections, myelodysplasia and leukaemia. The only...
9.
Devos T, Verhoef G, Steel E, Mazure D, Lewalle P, Bron D, et al.
Acta Haematol
. 2019 Jun;
142(4):197-207.
PMID: 31163431
Objectives: To assess interruptions/discontinuations of tyrosine kinase inhibitor (TKI) treatment in Belgian patients with chronic myeloid leukaemia (CML). Methods: This retrospective study included patients with TKI interruptions/discontinuations of ≥4 continuous...
10.
Van Aelst L, Mazure D, Cohen-Solal A
Curr Heart Fail Rep
. 2017 Jul;
14(4):223-234.
PMID: 28669000
Purpose Of Review: Heart failure (HF) is a common, costly, disabling, and deadly clinical syndrome and often associated with one or several co-morbidities complicating its treatment or worsening its symptoms....